Wed, March 23, 2011
[ Wed, Mar 23rd 2011 ] - Market Wire
El ensayo clnico de Fase III del frmaco en fase d .. itegravir, supera el objetivo principal de 48 sem
[ Wed, Mar 23rd 2011 ] - Market Wire
A.M. Best Withdraws Ratings of Priority Health Ca .. nc. and Peninsula Health Care, Inc. Due to Merger
[ Wed, Mar 23rd 2011 ] - Market Wire
Mesa Uranium Files 43-101 Report, Expands the Green Energy Project
[ Wed, Mar 23rd 2011 ] - Market Wire
Allezoe (ALZM) Announces Organ Transport Systems' Medical Advisory Members
[ Wed, Mar 23rd 2011 ] - Market Wire
Gilead to Offer Senior Notes
[ Wed, Mar 23rd 2011 ] - Market Wire
Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting
[ Wed, Mar 23rd 2011 ] - Market Wire
Phase III Clinical Trial of Gileada?s Investigational Elvitegravir Meets 48-Week Primary Objective
[ Wed, Mar 23rd 2011 ] - Market Wire
Prana Biotechnology Limited Raises A$6.12 Million in a Private Placement
[ Wed, Mar 23rd 2011 ] - Market Wire
Cambridge Heart Reports Results for the Fourth Quarter and Full Year of 2010
[ Wed, Mar 23rd 2011 ] - Market Wire
POZEN Announces Licensing Deal with Cilag GmbH, A .. Johnson & Johnson, for MT 400, Migraine Treatment
[ Wed, Mar 23rd 2011 ] - Market Wire
Nordion announces Phase III clinical trial to eva .. or liver metastases in colorectal cancer patients
[ Wed, Mar 23rd 2011 ] - Market Wire
CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction
[ Wed, Mar 23rd 2011 ] - Market Wire
Announcement of the Execution of a License Agreement for Unoprostone
Tue, March 22, 2011
[ Tue, Mar 22nd 2011 ] - Market Wire
New Acetadote® Formulation Now Available in the U.S.
[ Tue, Mar 22nd 2011 ] - Market Wire
Amyris aumenta sua capacidade de produo atrav©s de acordo com a Paraso Bioenergia
[ Tue, Mar 22nd 2011 ] - Market Wire
ISTA Pharmaceuticals Highlights BEPREVE(R) Clinic .. Academy of Allergy, Asthma and Immunology (AAAAI)
[ Tue, Mar 22nd 2011 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup
[ Tue, Mar 22nd 2011 ] - Market Wire
LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFO
[ Tue, Mar 22nd 2011 ] - Market Wire
Radient Pharmaceuticals Receives Additional Deficiency Notice From NYSE Amex
[ Tue, Mar 22nd 2011 ] - Market Wire
InSite Vision Announces Positive Phase 1/2 Result .. on of Pain and Inflammation after Cataract Surger
[ Tue, Mar 22nd 2011 ] - Market Wire
POZEN Files Motion for Preliminary Injunction in Treximet Patent Litigation
[ Tue, Mar 22nd 2011 ] - Market Wire
Amyris Adds Additional Production Capacity Through Agreement With Paraso Bioenergia
[ Tue, Mar 22nd 2011 ] - Market Wire
Pro-Pharmaceuticals Expands Patent Portfolio with New Patents in the U.S. and Australia
[ Tue, Mar 22nd 2011 ] - Market Wire
Emergent BioSolutions to Present at Needham & Company Healthcare Conference
[ Tue, Mar 22nd 2011 ] - Market Wire
Schiff Nutrition International, Inc. Announces Fiscal 2011 Third Quarter Results
[ Tue, Mar 22nd 2011 ] - Market Wire
Given Imaging to Present at the 10th Annual Needham Healthcare Conference
Mon, March 21, 2011
[ Mon, Mar 21st 2011 ] - Market Wire
2010 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS
[ Mon, Mar 21st 2011 ] - Market Wire
U.S. Physical Therapy to Present at the Sidoti Fi .. nual Emerging Growth Institutional Investor Forum
[ Mon, Mar 21st 2011 ] - Market Wire
Covidien Announces Interim Data Showing Parietex .. Significantly Reduces Early Pain Following Inguin
[ Mon, Mar 21st 2011 ] - Market Wire
30 p.m. ET
[ Mon, Mar 21st 2011 ] - Market Wire
Anacor Pharmaceuticals Secures $30 Million Loan Facility
[ Mon, Mar 21st 2011 ] - Market Wire
RXi Pharmaceuticals Presents New Preclinical RNAi .. one Mechanism and Biology of Silencing Conference
[ Mon, Mar 21st 2011 ] - Market Wire
Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA
[ Mon, Mar 21st 2011 ] - Market Wire
Amyris and U.S. Venture Announce Plans for Joint Venture in Development of Renewable Lubricants
[ Mon, Mar 21st 2011 ] - Market Wire
Biotech Sector Is a Hotbed of Takeover Speculation
[ Mon, Mar 21st 2011 ] - Market Wire
Teleflex Announces Retirement of 2004 Senior Notes
[ Mon, Mar 21st 2011 ] - Market Wire
Given Imaging Wins Patent Infringement Lawsuit in Germany
[ Mon, Mar 21st 2011 ] - Market Wire
XenoPort Reports Results from a Phase 2b Clinical .. il as Adjunctive Treatment for Patients with GERD
[ Mon, Mar 21st 2011 ] - Market Wire
Santarus and Pharming Announce RHUCIN Poster at A .. Allergy, Asthma & Immunology 2011 Annual Meeting
Sun, March 20, 2011
[ Sun, Mar 20th 2011 ] - Market Wire
Curis Announces Positive Results in Genentech Piv .. rial of GDC-0449 in Advanced Basal Cell Carcinoma
Fri, March 18, 2011
[ Fri, Mar 18th 2011 ] - Market Wire
Parere positivo del Comitato per i prodotti medic .. i per uso umano sul nuovo contraccettivo NOMAC-E2
[ Fri, Mar 18th 2011 ] - Market Wire
Forest Laboratories Announces Expiration of Hart- .. o Waiting Period for Acquisition of Clinical Data
[ Fri, Mar 18th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Therag
[ Fri, Mar 18th 2011 ] - Market Wire
Allezoe (ALZM) Announces Organ Transport Systems .. paring for Clinical Trials; Will Prioritize Heart
[ Fri, Mar 18th 2011 ] - Market Wire
Comit© voor geneesmiddelen voor menselijk gebrui .. deelt positief over nieuwe anticonceptie NOMAC-E2
[ Fri, Mar 18th 2011 ] - Market Wire
CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB
[ Fri, Mar 18th 2011 ] - Market Wire
Rotech Healthcare Inc. Announces Closing of Priva .. Offering of $290 Million Senior Second Lien Notes
[ Fri, Mar 18th 2011 ] - Market Wire
Committee for Medicinal Products for Human Use (C .. Opinion for New Contraception Offering, NOMAC-E2
[ Fri, Mar 18th 2011 ] - Market Wire
Teva Receives Positive Opinion for NOMAC/E2 from the European Committee for Medicinal Products
[ Fri, Mar 18th 2011 ] - Market Wire
Affymax Announces Pricing of Public Offering of Common Stock
[ Fri, Mar 18th 2011 ] - Market Wire
Algoma Central Corporation Announces Increase to Bought Deal Financing
[ Fri, Mar 18th 2011 ] - Market Wire
Cytokinetics Announces Fundamental Research in th .. yosin Activation Published in the Journal Science
[ Fri, Mar 18th 2011 ] - Market Wire
Declarao da Covidien sobre o impacto do terremoto japons
Thu, March 17, 2011
[ Thu, Mar 17th 2011 ] - Market Wire
Covidien Statement on the Impact of the Japanese Earthquake
[ Thu, Mar 17th 2011 ] - Market Wire
HearUSA Responds to Siemens Filing
[ Thu, Mar 17th 2011 ] - Market Wire
SunCoast RHIO Joins Connect HIN - Florida Health Information Network (FLHIN)
[ Thu, Mar 17th 2011 ] - Market Wire
CPEX Pharmaceuticals Advises Stockholders to Take .. Response to Mangrove Partnersa? Revised Proposal
[ Thu, Mar 17th 2011 ] - Market Wire
Antrim Energy Inc. Announces Closing of Financing
[ Thu, Mar 17th 2011 ] - Market Wire
CytRx Begins Phase 1b Clinical Trial with INNO-206 in Patients with Advanced Solid Tumors
[ Thu, Mar 17th 2011 ] - Market Wire
Radient Pharmaceuticals Hires DLA Piper to Defend Company Against Class Action Lawsuit
[ Thu, Mar 17th 2011 ] - Market Wire
Self Funding Administrators Corporation Joins American CareSource's Growing Client Portfolio
[ Thu, Mar 17th 2011 ] - Market Wire
ImmuCell Announces Sales and Marketing Collaboration With AgriLabs
[ Thu, Mar 17th 2011 ] - Market Wire
Prime Equity Research Initiates Independent Coverage On Fresh Start
[ Thu, Mar 17th 2011 ] - Market Wire
Oncolytics Biotech® Inc. Announces 2010 Year End Results
[ Thu, Mar 17th 2011 ] - Market Wire
Alnylam Responds to Tekmira Complaint
[ Thu, Mar 17th 2011 ] - Market Wire
AngioDynamics to Report Fiscal 2011 Third Quarter .. Results and Hold Conference Call on April 5, 2011
Wed, March 16, 2011
[ Wed, Mar 16th 2011 ] - Market Wire
CEO da Covidien deixar o cargo em 1 de julho. Seu Sucessor j foi Nomeado
[ Wed, Mar 16th 2011 ] - Market Wire
El 1 de julio se retira el CEO de Covidien; ya se ha nombrado el sucesor
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien elige como presidente y director ejecutivo a Jose E. Almeida
[ Wed, Mar 16th 2011 ] - Market Wire
St. Jude Medical Celebrates Two Millionth Mechanical Heart Valve Implant
[ Wed, Mar 16th 2011 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES NEW CHIEF FINANCIAL AND OPERATIONS OFFICER
[ Wed, Mar 16th 2011 ] - Market Wire
Study Shows SANUWAVEa?s Dermapace is Significantl .. ric Oxygen Therapy in Healing Chronic Diabetic Fo
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien Elects Jose E. Almeida President and Chief Executive Officer
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien CEO to Retire July 1; Successor Named
[ Wed, Mar 16th 2011 ] - Market Wire
Covidiens CEO scheidet am 1. Juli aus dem Amt; Nachfolger ernannt
[ Wed, Mar 16th 2011 ] - Market Wire
CEO di Covidien in pensione dal 1 luglio - nominato successore
[ Wed, Mar 16th 2011 ] - Market Wire
TSO3 DISCLOSES FOURTH QUARTER AND FULL YEAR 2010 .. SCAL RESULTS AND UPDATES ON SUBSEQUENT ACTIVITIES
[ Wed, Mar 16th 2011 ] - Market Wire
Amedisys Presents Home Care and Hospice Face-to-Face Requirements Webinar to Health Care Leaders
[ Wed, Mar 16th 2011 ] - Market Wire
AlphaRx Provides Corporate and Development Update
Tue, March 15, 2011
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien bepaalt contant kwartaaldividend en maak .. n van jaarlijkse algemene vergadering 2011 bekend
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien Declares Quarterly Cash Dividend and Announces Results from 2011 Annual General Meeting
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien setzt vierteljhrliche Bardividende fest .. ibt Ergebnisse der Jahresversammlung 2011 bekannt
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien d©clare un dividende trimestriel en esp .. les r©sultats de son assembl©e g©n©rale 2011
[ Tue, Mar 15th 2011 ] - Market Wire
Exelixis Announces Exercise in Full of Option to .. es and Closing of Public Offering of Common Stock
[ Tue, Mar 15th 2011 ] - Market Wire
Concentra Successfully Deploys ZeOmegaa?s Integrated Workflow Solution
[ Tue, Mar 15th 2011 ] - Market Wire
Seattle Genetics and Millennium Expand Antibody-Drug Conjugate Collaboration
[ Tue, Mar 15th 2011 ] - Market Wire
Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2010 Financial Results
[ Tue, Mar 15th 2011 ] - Market Wire
Unigene Doses First Patient in Phase 2 Oral PTH S .. Treatment of Osteoporosis in Postmenopausal Women
[ Tue, Mar 15th 2011 ] - Market Wire
Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents
[ Tue, Mar 15th 2011 ] - Market Wire
Merck to Present at Barclays Capital 2011 Global Healthcare Conference
[ Tue, Mar 15th 2011 ] - Market Wire
Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
[ Tue, Mar 15th 2011 ] - Market Wire
Illumina Prices $800 Million Convertible Senior Notes
Mon, March 14, 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Incytea?s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
[ Mon, Mar 14th 2011 ] - Market Wire
Teva to Present at the Barclays Capital 2011 Global Healthcare Conference
[ Mon, Mar 14th 2011 ] - Market Wire
Health Net, Inc. Investigating Unaccounted-for Server Drives
[ Mon, Mar 14th 2011 ] - Market Wire
30 AM E.T.
[ Mon, Mar 14th 2011 ] - Market Wire
Repligen Reports Positive Phase 3 Clinical Trial Results for RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ] - Market Wire
Bristol-Myers Squibb Awards Grant to the American .. tion to Address U.S. HIV Medical Workforce Shorta
[ Mon, Mar 14th 2011 ] - Market Wire
HemaCare Reports Fourth Quarter and Year End Results
[ Mon, Mar 14th 2011 ] - Market Wire
Medtronic Announces Global Launch of New Heart Va .. Ring Designed to Adapt to Hearta?s Natural Valve
[ Mon, Mar 14th 2011 ] - Market Wire
Thermo Fisher Scientific Extends Legacy of Innovation at Pittcon 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Anacor Pharmaceuticals Completes Enrollment in Phase 2b Trial of AN2728 for Psoriasis
[ Mon, Mar 14th 2011 ] - Market Wire
Repligen Announces Conference Call to Discuss Pha .. cal Trial Results of RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ] - Market Wire
Covidien Announces New Data on Hernia and Abdomin .. ir Products to Be Presented at Hernia Repair 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Human Genome Sciences Appoints George Morrow to its Board of Directors
Sun, March 13, 2011
[ Sun, Mar 13th 2011 ] - Market Wire
DaVita Enhances Already Strong Governance Policies
Sat, March 12, 2011
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead raccomanda di rifiutare la?offerta di minigara presentata da TRC Capital Corporation
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead empfiehlt Ablehnung von Mini-bernahmeangebot durch TRC Capital Corporation
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead Adviseert Afwijzing van Mini-Overnamebod door TRC Capital Corporation
Fri, March 11, 2011
[ Fri, Mar 11th 2011 ] - Market Wire
The Rosen Law Firm Files Class Action Lawsuit Cha .. ceuticals Corporation With Securities Fraud - RPC
[ Fri, Mar 11th 2011 ] - Market Wire
Edwards Lifesciences Acquires Embrella Cardiovascular, Inc.
[ Fri, Mar 11th 2011 ] - Market Wire
Aetna Recognized by the National Business Group on Health for Reducing Disparities in Care
[ Fri, Mar 11th 2011 ] - Market Wire
Orthofix Sports Medicine Launches Three New Products in March
[ Fri, Mar 11th 2011 ] - Market Wire
Obagi Medical Products to Present at the 23rd Annual Roth OC Growth Stock Conference
[ Fri, Mar 11th 2011 ] - Market Wire
NovaDel Pharma Inc. to Present at ROTH 23rd Annual OC Growth Stock Conference
[ Fri, Mar 11th 2011 ] - Market Wire
Human Genome Sciences oraz GlaxoSmithKline oglasz .. DA na wprowadzenie na rynek BENLYSTA® (Belimumab
[ Fri, Mar 11th 2011 ] - Market Wire
Equity Research on Elan Corp. plc and Valeant Pha .. Drug Delivery Sector Sees Opportunities and Growi
[ Fri, Mar 11th 2011 ] - Market Wire
CytRx Reports 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Synta Announces Clinical Program Updates and 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Human Genome Sciences????????????BENLYSTA® (?????) ?FDA??????????????
[ Fri, Mar 11th 2011 ] - Market Wire
Centric Health Reports Solid 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Covidien????????????????FDA??
Thu, March 10, 2011
[ Thu, Mar 10th 2011 ] - Market Wire
Covidien recibe la autorizacin de la FDA para los .. basados en uranio de bajo enriquecimiento produci
[ Thu, Mar 10th 2011 ] - Market Wire
Covidien obtient la?approbation de la FDA pour un .. rique du Sud bas© sur de la?uranium faiblement e
[ Thu, Mar 10th 2011 ] - Market Wire
A Brighter Decade Ahead for Biotech - In-Depth Re .. ch Featuring Biodel Inc. and MannKind Corporation
[ Thu, Mar 10th 2011 ] - Market Wire
Anacor Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
[ Thu, Mar 10th 2011 ] - Market Wire
CompCare Expands Management Team to Drive Continued Innovation and Bottom-Line Growth
[ Thu, Mar 10th 2011 ] - Market Wire
Northstar Healthcare Reports 2010 Results
[ Thu, Mar 10th 2011 ] - Market Wire
Given Imaging Receives FDA Clearance for Expanded PillCam(R) SB Indications
[ Thu, Mar 10th 2011 ] - Market Wire
Columbia Laboratories Reports Fourth Quarter and Year End 2010 Financial Results
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences e GlaxoSmithKline annuncian .. zione da parte dell'FDA per il BENLYSTA® (belimu
[ Thu, Mar 10th 2011 ] - Market Wire
Santarus Initiates Phase I Clinical Study with SAN-300
[ Thu, Mar 10th 2011 ] - Market Wire
BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences und GlaxoSmithKline melden .. (Belimumab) zur Behandlung von systemischem Lupus
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences et GlaxoSmithKline annoncen .. ur BENLYSTA® (Belimumab) dans le traitement du l
Wed, March 9, 2011
[ Wed, Mar 09th 2011 ] - Market Wire
The Law Offices of Vincent Wong Announce an Inves .. hes of Fiduciary Duty by the Board of TomoTherapy
[ Wed, Mar 09th 2011 ] - Market Wire
A.M. Best Revises Outlook to Stable for Coventry Health Care, Inc. and Its Subsidiaries
[ Wed, Mar 09th 2011 ] - Market Wire
Renegade Petroleum Ltd. Announces Closing of $41.9 Million Bought Deal Financing
[ Wed, Mar 09th 2011 ] - Market Wire
Lpath Granted Another Key U.S. Patent Related to iSONEP and ASONEP Drug Programs
[ Wed, Mar 09th 2011 ] - Market Wire
Fight Colorectal Cancer and Genomic Health Launch Unique Online Resource for Colon Cancer Patients
[ Wed, Mar 09th 2011 ] - Market Wire
Avid Bioservices to Present Comparability Studies .. ge-Scale Manufacturing of Clinical-Stage Antibody
[ Wed, Mar 09th 2011 ] - Market Wire
Corcept Therapeutics Announces Fourth Quarter Results and Corporate and Development Update
[ Wed, Mar 09th 2011 ] - Market Wire
Biotech's Response to the MRSA Epidemic
[ Wed, Mar 09th 2011 ] - Market Wire
DUSA Pharmaceuticals to Present at Roth Capital Partners 23rd Annual OC Growth Stock Conference
[ Wed, Mar 09th 2011 ] - Market Wire
Opexa Therapeutics Reports Year End 2010 Financial Results and Provides Corporate Update
[ Wed, Mar 09th 2011 ] - Market Wire
Biomagnetics to Receive Funding From BIOTECH Deve .. pment Partners for Commercialization of Biosensor
[ Wed, Mar 09th 2011 ] - Market Wire
Hythiam to Present at the Roth 23rd Annual OC Growth Stock Conference
[ Wed, Mar 09th 2011 ] - Market Wire
Lilly CEO Calls for Biopharmaceutical Industry Ch .. es and Policies That Encourage Medical Innovation
Tue, March 8, 2011
[ Tue, Mar 08th 2011 ] - Market Wire
Medtronic CareLink® Network Remote Monitoring He .. Improve Patient Care and Reduce Healthcare Costs
[ Tue, Mar 08th 2011 ] - Market Wire
Derma Sciences to Present at the Roth Capital Partners Growth Stock Conference
[ Tue, Mar 08th 2011 ] - Market Wire
China Kanghui Holdings Announces Participation in Upcoming Investor Events
[ Tue, Mar 08th 2011 ] - Market Wire
Arrowhead Research to Present at the Roth Capital .. 3rd Annual OC Growth Stock Conference on March 16
[ Tue, Mar 08th 2011 ] - Market Wire
ZIOPHARM to Present at Barclays Capital 2011 Global Healthcare Conference
[ Tue, Mar 08th 2011 ] - Market Wire
Yellowhead Mining Reports Positive Results of Preliminary Economic Assessment
[ Tue, Mar 08th 2011 ] - Market Wire
Marina Biotech, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
[ Tue, Mar 08th 2011 ] - Market Wire
Dynavax Reports Fourth Quarter and Year End 2010 Financial Results
[ Tue, Mar 08th 2011 ] - Market Wire
Applied DNA Sciences, Inc. Migrates to the OTCQB Tier of the OTC Marketplace
[ Tue, Mar 08th 2011 ] - Market Wire
Cytori Patents Method of Making Stem and Regenerative Cell-Enriched Fat Grafts
[ Tue, Mar 08th 2011 ] - Market Wire
Peregrine Announces Initiation of Lung Cancer Investigator-Sponsored Trial
[ Tue, Mar 08th 2011 ] - Market Wire
GTSO JV Secures NewRare Earth Mining Lease in Mongolia
[ Tue, Mar 08th 2011 ] - Market Wire
Healthways Announces Planned Transition of President, Stefen Brueckner, to Senior Advisor Role
Mon, March 7, 2011
[ Mon, Mar 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of TomoTherapy Incorporated, in Connection wit
[ Mon, Mar 07th 2011 ] - Market Wire
Prana to Present at Cowen and Company Health Care Conference
[ Mon, Mar 07th 2011 ] - Market Wire
Charles River to Present at March Conferences
[ Mon, Mar 07th 2011 ] - Market Wire
TomoTherapy Incorporated Shareholder Investigatio .. m Concerning Sale to Accuray Incorporated a" TOMO
[ Mon, Mar 07th 2011 ] - Market Wire
Kendall Law Group Investigates TomoTherapy Inc. Acquisition for Shareholders
[ Mon, Mar 07th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Investigates Buyout of TomoTherapy Incorporated - TOMO
[ Mon, Mar 07th 2011 ] - Market Wire
Stellar's Common Shares Now Trading on OTCQB
[ Mon, Mar 07th 2011 ] - Market Wire
Daxor Announces Publication of Research Article D .. 100 Data to Guide Shock Resuscitation Led to Sign
[ Mon, Mar 07th 2011 ] - Market Wire
Allied Healthcare International Inc. Acquires ScotHomecare
[ Mon, Mar 07th 2011 ] - Market Wire
Amedisys to Present at the Raymond James and Asso .. es 32nd Annual Institutional Investors Conference
[ Mon, Mar 07th 2011 ] - Market Wire
Rotech Healthcare Inc. Announces Proposed Private .. Offering of $290 Million Senior Second Lien Notes
[ Mon, Mar 07th 2011 ] - Market Wire
Compugen Announces Positive Animal Model Results .. de Predicted to Block Protein-Protein Interaction
[ Mon, Mar 07th 2011 ] - Market Wire
ZIOPHARM and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin in Asia
Sat, March 5, 2011
[ Sat, Mar 05th 2011 ] - Market Wire
Harper Creek Drill Hole HC10-82 Confirms Minerali .. thern Limit of Drill Holes in 2010 Resource Model
Fri, March 4, 2011
[ Fri, Mar 04th 2011 ] - Market Wire
DaVita Is Recognized for Clinical and Operational Excellence Early in 2011
[ Fri, Mar 04th 2011 ] - Market Wire
CPEX Receives Letter from Athyrium Capital Management
[ Fri, Mar 04th 2011 ] - Market Wire
Court Ruling Clears Way for Jury Trial in $1 Billion Texas Medicaid Whistleblower Lawsuit
[ Fri, Mar 04th 2011 ] - Market Wire
Medtronic Announces European Launch of Achievea" Mapping Catheter
[ Fri, Mar 04th 2011 ] - Market Wire
PacificHealth Laboratories Reports 2010 Financial Results
[ Fri, Mar 04th 2011 ] - Market Wire
Amyris to Webcast Management Presentation
[ Fri, Mar 04th 2011 ] - Market Wire
Aoxing Pharmaceutical Company to Present at Rodman & Renshaw Annual China Investment Conference
[ Fri, Mar 04th 2011 ] - Market Wire
Drug Approval Process May Be Faster but It's Also Stricter
[ Fri, Mar 04th 2011 ] - Market Wire
Peregrine to Report Third Quarter Fiscal Year 201 .. cial Results After Market Close on March 11, 2011
[ Fri, Mar 04th 2011 ] - Market Wire
ISTA Pharmaceuticals Files Citizen Petition (CP) With U.S. Food and Drug Administration
[ Fri, Mar 04th 2011 ] - Market Wire
Centric Health Terminates Discussions to Acquire DNPI Group
[ Fri, Mar 04th 2011 ] - Market Wire
Assisted Living Concepts, Inc. Announces Continue .. te Pay Strategy Successes; Completes Re-Financing
[ Fri, Mar 04th 2011 ] - Market Wire
Amyris Contracts for Biofenea" Manufacture with Antibiticos, S.A.
Thu, March 3, 2011
[ Thu, Mar 03rd 2011 ] - Market Wire
IDC ANOUNCES SUCCESSFUL CLOSURE OF NON-BROKERED PRIVATE PLACEMENT
[ Thu, Mar 03rd 2011 ] - Market Wire
Northstar Healthcare to announce Q4 and Year End .. results March 9 and hold conference call March 10
[ Thu, Mar 03rd 2011 ] - Market Wire
Shoal Point Closes Additional Financing For $2,38 .. d Provides Update on Offshore Drilling on EL 1070
[ Thu, Mar 03rd 2011 ] - Market Wire
SpectraScience, Inc. Addresses Commencement of Trading on OTCQB
[ Thu, Mar 03rd 2011 ] - Market Wire
Belo Sun Announces $45 Million Equity Offering
[ Thu, Mar 03rd 2011 ] - Market Wire
Sentinel Rock Oil Inc. and Sundance Energy Corpor .. s Commencement of 26 Square KM 3D Seismic Program
[ Thu, Mar 03rd 2011 ] - Market Wire
Unigene to Announce Fourth Quarter and Full Year 2010 Financial Results on March 10, 2011
[ Thu, Mar 03rd 2011 ] - Market Wire
Exelixis Announces Webcasts of Investor Events in March
[ Thu, Mar 03rd 2011 ] - Market Wire
Health Management Associates, Inc. to Present at .. es 32nd Annual Institutional Investors Conference
[ Thu, Mar 03rd 2011 ] - Market Wire
DURATION-6 Top-Line Study Results Announced
[ Thu, Mar 03rd 2011 ] - Market Wire
BIOLASE Issued New Patent Supporting Use of Laser .. for Treating Eye Conditions, Including Presbyopia
[ Thu, Mar 03rd 2011 ] - Market Wire
Dynavax to Present at the Cowen Healthcare Conference

NuPathe to Present at the Roth 23rd Annual OC Growth Stock Conference


//health-fitness.news-articles.net/content/2011/ .. roth-23rd-annual-oc-growth-stock-conference.html
Published in Health and Fitness on Friday, March 11th 2011 at 9:16 GMT by Market Wire   Print publication without navigation


CONSHOHOCKEN, PA--(Marketwire - March 11, 2011) - NuPathe Inc. (NASDAQ: [ PATH ]), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders, today announces that [ Jane Hollingsworth ], chief executive officer, will present a company overview at the Roth 23rd Annual OC Growth Stock Conference on Tuesday, March 15, 2011 at 7:30 p.m. EDT. The conference is being held at The Ritz Carlton in Laguna Niguel, CA.

A live audio webcast of the presentation will be available via the "Investor Relations" page of the NuPathe website, [ www.nupathe.com ]. Please log on through NuPathe's website approximately 10 minutes prior to the scheduled start time. A replay of the webcast will also be archived on the Company's website for 90 days following the call.

About NuPathe

NuPathe Inc. ([ www.nupathe.com ]) is a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. NuPathe's most advanced product candidate, [ Zelrix ], is a single-use, transdermal sumatriptan patch being developed for the treatment of acute migraine. In addition to Zelrix, NuPathe has two proprietary product candidates in preclinical development: [ NP201 ] for the continuous symptomatic treatment of Parkinson's disease, and [ NP202 ] for the long-term treatment of schizophrenia and bipolar disorder.


Publication Contributing Sources